Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19)

Assessment of Tocilizumab (Humanized Monoclonal Antibody) for Therapeutic Efficacy and Clinical Safety in Patients with Coronavirus Disease (COVID-19)

<i>Background and objectives</i>: COVID-19 patients exhibit a broad range of manifestations, presenting with a flu-like respiratory tract infection that can advance to a systemic and severe disease characterized by pneumonia, pulmonary edema, severe damage to the airways, and acute respi...

Full description

Bibliographic Details
Main Authors: Sami Ullah, Radhya Abid, Sana Haider, Fazli Khuda, Ghadeer M. Albadrani, Jawaher A. Abdulhakim, Ahmed E. Altyar, Mohamed M. Abdel-Daim, Syed Muhammad Ashhad Halimi, Atif Ali Khan Khalil
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Medicina
Subjects:
COVID-19
tocilizumab
inflammatory parameters
coagulopathy
Online Access:https://www.mdpi.com/1648-9144/58/8/1076

Internet

https://www.mdpi.com/1648-9144/58/8/1076

Similar Items